Active Investments

Devoted Health

Private

Element Biosciences

Private

Inscripta

Private

Suki

Private

Renew

Private

Encoded Therapeutics

Private

Lyra Health

Private

Stride Health

Private

10X Genomics

Public (NYSE: TXG)

Doctor on Demand

Private

Grand Rounds

Private

Kyruus

Private

Hua Medicine

Private

CloudFlare

Public (NASDAQ: NET)

Castlight Health

Public (NYSE: CSLT)

Intarcia Therapeutics

Private

Alumni Investments

PowerVision

Acquired by Alcon

Ariosa Diagnostics

Acquired by Roche

Fate Therapeutics

Public (NASDAQ: FATE)

Zeltiq

Public (NASDAQ: ZLTQ)

Receptos

Public (NASDAQ: RCPT)

Ikaria

Acquired by Madison Dearborn

Achaogen

Public (NASDAQ: AKAO)

CodeRyte

Acquired by 3M

Sirna Therapeutics

Acquired by Merck

Ensure Medical

Acquired by Cordis

Vitae Pharma

Acquired by Allergan

XenoPort

Public (NASDAQ: XNPT)

athenahealth

Public (NASDAQ: ATHN)

Ironwood Pharma

Public (NASDAQ: IRWD)

Illumina

Public (NASDAQ: ILMN)

Bryan Roberts Partner

Focus Areas: Healthcare IT, Biotechnology, Diagnostics, Medical Devices
Location: Palo Alto

Bryan joined Venrock as a Kauffman Fellow in 1997. He is based in Palo Alto and invests broadly across the healthcare industry. Bryan is currently involved with numerous public and private companies including 10X Genomics, Castlight Health, CloudFlare, Grand Rounds, Intarcia, and Lyra Health. Past investments include Ariosa Diagnostics (acquired by Roche), athenahealth (NASDAQ: ATHN), Ikaria (acquired by Mallinckrodt), Illumina (NASDAQ: ILMN), Ironwood Pharmaceuticals (NASDAQ: IRWD), Sirna Therapeutics (acquired by Merck), and Zeltiq (acquired by Allergan). Bryan was named a Henry Crown Fellow by the Aspen Institute in 2006 and has ranked on Forbes’ Midas List eleven times, 2008 – 2019. In 2019, the National Venture Capital Association presented him with the Excellence in Healthcare Innovation Award, in recognition of his dedication to healthcare innovation.

Immediately prior to joining Venrock, Bryan received his Ph.D. in Chemistry & Chemical Biology from Harvard University. He received his B.A. from Dartmouth College.

Podcasts

Writing

News

Active Companies

Devoted Health

Element Biosciences

Inscripta

Inscripta ForgeCraft™ technology enables rapid exploration of the genetic landscape at the whole genome scale, unlocking every cell's fullest potential

Suki

Suki™ is an artificial intelligence-powered, voice-enabled digital assistant for doctors.

Renew

Encoded Therapeutics

Lyra Health

Stride Health

10X Genomics

10X Genomics provides an innovative genomics platform that delivers additional genetic information by dramatically upgrading the capabilities of existing short read sequencers.

Doctor on Demand

Grand Rounds

Kyruus

Kyruus delivers provider search, scheduling, and data management solutions that help health systems match patients with the right providers.

Hua Medicine

CloudFlare

Castlight Health

Intarcia Therapeutics

Alumni Companies

PowerVision

Ariosa Diagnostics

Fate Therapeutics

Zeltiq

Receptos

Ikaria

Achaogen

CodeRyte

Sirna Therapeutics

Ensure Medical

Vitae Pharma

Vitae Pharmaceuticals is a drug discovery company bringing together the basic pre-clinical sciences to form a powerful, efficient and effective platform for drug design and development.

XenoPort

athenahealth

Ironwood Pharma

Illumina

Illumina has developed a comprehensive line of products that address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine.